UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Multinational drugmakers sweep local sales in Q3
by So Jae-hyeon
2017-12-04 16:08
Pfizer Korea’s sales dwindle in generic drug market
by So Jae-hyeon
2017-12-04 11:55
Korea United wins patent suit against Daewoong
by So Jae-hyeon
2017-12-01 14:03
Biopharmaceutical firms' liver treatments draw attention
by So Jae-hyeon
2017-11-30 12:02
GL PharmTech eyes on new drug development, production
by So Jae-hyeon
2017-11-29 11:55
라인
Celltrion joins local drugmakers to tap US generic market
by So Jae-hyeon
2017-11-27 12:04
Will LG succeed in prescription, OTC drug markets?
by So Jae-hyeon
2017-11-23 15:03
Hanmi, Korea United in patent battle over Fenocid
by So Jae-hyeon
2017-11-21 14:42
Pfizer’s ‘quality generic’ slogan leads to dismal results
by So Jae-hyeon
2017-11-20 11:57
Multinationals struggle in battle with local drugmakers
by So Jae-hyeon
2017-11-16 16:59
라인
Multinationals often cause drug shortages
by So Jae-hyeon
2017-11-14 15:28
Pfizer’s Viagra embarrassingly defeated by Hanmi’s copy
by So Jae-hyeon
2017-11-13 15:34
CJ healthcare workers worry about ‘eat-and-run’ capital’s buyout
by So Jae-hyeon
2017-11-13 13:11
Sales of clot buster Lixiana skyrocket in Q3
by So Jae-hyeon
2017-11-08 15:15
Drugmakers vie to develop ‘easy-to-use’ dementia treatments
by So Jae-hyeon
2017-11-08 15:11
라인
Yuhan’s new security system under fire for monitoring staffs through GPS
by So Jae-hyeon
2017-11-07 14:36
TissueGene shares trade low in Kosdaq debut
by So Jae-hyeon
2017-11-06 15:47
-
이전
11
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top